| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
123,887 |
108,634 |
$67.54M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
101,503 |
92,901 |
$39.21M |
| G0378 |
Hospital observation service, per hour |
33,804 |
18,624 |
$9.94M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
47,839 |
44,312 |
$9.80M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
26,441 |
23,835 |
$8.74M |
| OP370 |
|
18,838 |
17,494 |
$3.34M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,624 |
2,532 |
$3.02M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
59,060 |
45,418 |
$1.94M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
21,962 |
20,646 |
$1.90M |
| 70450 |
Computed tomography, head or brain; without contrast material |
26,809 |
24,711 |
$1.71M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
22,721 |
6,370 |
$1.57M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
943 |
918 |
$1.56M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
68,101 |
58,121 |
$1.54M |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
7,208 |
1,156 |
$1.50M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
37,072 |
31,048 |
$1.28M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
40,807 |
9,452 |
$1.27M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
7,082 |
6,752 |
$1.26M |
| OP270 |
|
54,694 |
46,996 |
$1.17M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,493 |
2,438 |
$1.14M |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
859 |
772 |
$1.02M |
| 93975 |
|
7,808 |
7,471 |
$999K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
22,226 |
18,205 |
$983K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,134 |
1,093 |
$974K |
| OP710 |
|
14,416 |
13,240 |
$968K |
| 71046 |
Radiologic examination, chest; 2 views |
39,776 |
37,491 |
$953K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
7,460 |
7,363 |
$911K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
1,813 |
1,735 |
$877K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
532 |
440 |
$820K |
| 59025 |
Fetal non-stress test |
3,745 |
2,641 |
$804K |
| 76830 |
Ultrasound, transvaginal |
8,959 |
8,599 |
$795K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
14,856 |
13,587 |
$794K |
| 76801 |
|
6,700 |
5,902 |
$780K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
182,326 |
136,987 |
$767K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
46,335 |
38,371 |
$764K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
25,470 |
23,906 |
$716K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
10,398 |
9,643 |
$708K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
86,977 |
72,673 |
$703K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
177,633 |
138,642 |
$685K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
5,640 |
5,112 |
$642K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
8,875 |
8,487 |
$638K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
7,549 |
7,211 |
$629K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,978 |
1,585 |
$596K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
4,120 |
3,918 |
$576K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
11,221 |
10,502 |
$569K |
| 96376 |
|
24,674 |
15,302 |
$558K |
| OP250 |
|
127,202 |
65,086 |
$532K |
| 62323 |
|
308 |
307 |
$511K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
4,016 |
3,824 |
$504K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
514 |
493 |
$494K |
| 71045 |
Radiologic examination, chest; single view |
38,149 |
34,253 |
$488K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
4,703 |
4,535 |
$487K |
| 70498 |
|
4,342 |
4,073 |
$484K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,583 |
2,453 |
$470K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
16,390 |
13,538 |
$468K |
| 71250 |
|
3,852 |
3,626 |
$468K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,693 |
1,530 |
$467K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13,256 |
12,318 |
$466K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
12,297 |
3,296 |
$460K |
| 73630 |
|
11,349 |
10,485 |
$455K |
| 93970 |
|
6,322 |
6,021 |
$450K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
4,434 |
4,125 |
$450K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,786 |
1,727 |
$440K |
| 70496 |
|
4,371 |
4,097 |
$418K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
8,946 |
8,602 |
$416K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
19,400 |
6,601 |
$408K |
| 95811 |
|
265 |
265 |
$400K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
28,436 |
26,074 |
$399K |
| 93971 |
|
4,958 |
4,709 |
$398K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
4,102 |
3,073 |
$396K |
| 64493 |
|
231 |
228 |
$381K |
| 64483 |
|
209 |
200 |
$372K |
| 95806 |
|
1,299 |
1,277 |
$365K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
8,029 |
7,671 |
$355K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
33,332 |
22,569 |
$349K |
| 70486 |
|
3,235 |
3,110 |
$333K |
| 76770 |
|
3,813 |
3,636 |
$314K |
| 73130 |
|
8,764 |
8,146 |
$314K |
| OP272 |
|
7,537 |
7,001 |
$310K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14,390 |
11,054 |
$303K |
| 90791 |
Psychiatric diagnostic evaluation |
4,391 |
4,037 |
$295K |
| 76642 |
|
2,613 |
2,420 |
$275K |
| 77066 |
Tomosynthesis, mammo |
1,656 |
1,615 |
$267K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
6,438 |
6,129 |
$266K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
10,741 |
9,941 |
$265K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,883 |
1,846 |
$264K |
| 80076 |
|
80,896 |
69,017 |
$263K |
| 84484 |
|
60,112 |
47,051 |
$258K |
| 73610 |
|
7,821 |
7,286 |
$258K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
8,146 |
6,222 |
$257K |
| 80329 |
|
13,189 |
11,234 |
$245K |
| 76813 |
|
1,919 |
1,869 |
$239K |
| 64635 |
|
122 |
111 |
$229K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
5,959 |
5,868 |
$225K |
| 27096 |
|
111 |
111 |
$218K |
| 47562 |
|
160 |
154 |
$214K |
| 73564 |
|
8,468 |
7,756 |
$201K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,316 |
789 |
$200K |
| 72141 |
|
863 |
833 |
$198K |
| 76536 |
|
1,751 |
1,722 |
$198K |
| 72110 |
|
2,262 |
2,193 |
$182K |
| 83735 |
|
70,103 |
52,923 |
$180K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
163 |
141 |
$180K |
| 97597 |
|
1,557 |
803 |
$179K |
| 94799 |
|
2,278 |
1,284 |
$176K |
| 80320 |
|
18,042 |
14,615 |
$172K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
11,357 |
10,961 |
$164K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
580 |
348 |
$164K |
| 70491 |
|
1,357 |
1,286 |
$162K |
| 84443 |
Thyroid stimulating hormone (TSH) |
13,090 |
12,047 |
$161K |
| 73030 |
|
7,116 |
6,590 |
$151K |
| 85610 |
|
51,285 |
44,846 |
$147K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
11,357 |
10,964 |
$145K |
| 83880 |
|
15,848 |
14,126 |
$142K |
| OP258 |
|
66,340 |
39,554 |
$138K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
442 |
429 |
$134K |
| 83690 |
|
58,242 |
50,900 |
$131K |
| OP229 |
|
2,466 |
2,352 |
$125K |
| 94761 |
|
8,466 |
7,274 |
$123K |
| 80053 |
Comprehensive metabolic panel |
10,955 |
8,515 |
$120K |
| 73502 |
|
3,724 |
3,425 |
$117K |
| 85730 |
|
40,107 |
36,338 |
$116K |
| J9271 |
Injection, pembrolizumab, 1 mg |
20 |
12 |
$116K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
321 |
309 |
$113K |
| 82550 |
|
29,250 |
25,081 |
$113K |
| 74022 |
|
4,627 |
4,355 |
$112K |
| 82977 |
|
19,589 |
17,896 |
$111K |
| 82948 |
|
29,700 |
17,966 |
$108K |
| 97162 |
|
4,234 |
3,892 |
$106K |
| 74240 |
|
893 |
878 |
$105K |
| J1756 |
Injection, iron sucrose, 1 mg |
1,672 |
582 |
$104K |
| 97161 |
|
4,301 |
4,057 |
$103K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,019 |
282 |
$102K |
| 72100 |
|
5,311 |
5,075 |
$101K |
| A9270 |
Non-covered item or service |
344,361 |
91,818 |
$99K |
| 88342 |
|
4,733 |
4,511 |
$97K |
| 73110 |
|
5,029 |
4,675 |
$95K |
| 72050 |
|
1,271 |
1,235 |
$92K |
| 77065 |
Tomosynthesis, mammo |
1,161 |
1,083 |
$91K |
| 76870 |
|
1,606 |
1,526 |
$89K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
425 |
418 |
$88K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25,016 |
23,217 |
$87K |
| 86900 |
|
12,246 |
10,746 |
$84K |
| 87040 |
|
16,907 |
14,339 |
$84K |
| 36415 |
Collection of venous blood by venipuncture |
33,964 |
24,034 |
$83K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
4,986 |
1,746 |
$82K |
| 87507 |
|
743 |
710 |
$77K |
| 86850 |
|
8,646 |
7,593 |
$76K |
| J3490 |
Unclassified drugs |
46,676 |
26,021 |
$75K |
| C1889 |
Implantable/insertable device, not otherwise classified |
388 |
367 |
$74K |
| 81001 |
|
52,279 |
47,431 |
$74K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
108 |
69 |
$72K |
| 81003 |
|
34,367 |
31,761 |
$72K |
| 96367 |
|
3,552 |
2,819 |
$71K |
| 83605 |
|
15,108 |
13,146 |
$69K |
| 88341 |
|
1,221 |
1,130 |
$65K |
| 73590 |
|
4,022 |
3,722 |
$64K |
| 83970 |
|
713 |
711 |
$63K |
| 81025 |
|
22,550 |
20,236 |
$61K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
1,382 |
756 |
$60K |
| 80061 |
Lipid panel |
6,484 |
6,181 |
$59K |
| 74174 |
|
916 |
880 |
$58K |
| 74018 |
|
2,606 |
2,464 |
$58K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
25 |
25 |
$58K |
| 72131 |
|
861 |
823 |
$57K |
| 96417 |
|
409 |
261 |
$57K |
| 76882 |
|
742 |
710 |
$55K |
| 73080 |
|
2,972 |
2,818 |
$55K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,752 |
2,537 |
$54K |
| 73090 |
|
2,991 |
2,804 |
$54K |
| 85027 |
|
15,702 |
12,116 |
$54K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,486 |
15,072 |
$54K |
| 12001 |
|
1,264 |
1,216 |
$53K |
| 84100 |
|
17,026 |
11,798 |
$53K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
3,055 |
2,801 |
$51K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
745 |
563 |
$50K |
| 86901 |
|
12,338 |
10,766 |
$49K |
| 93017 |
|
500 |
481 |
$49K |
| C1769 |
Guide wire |
1,125 |
966 |
$48K |
| 72040 |
|
1,931 |
1,831 |
$48K |
| 72070 |
|
1,386 |
1,332 |
$48K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,177 |
1,145 |
$48K |
| 84702 |
|
10,367 |
9,115 |
$45K |
| 76376 |
|
1,641 |
1,495 |
$44K |
| 90715 |
|
5,225 |
5,069 |
$43K |
| 80365 |
|
2,306 |
1,220 |
$41K |
| 29125 |
|
1,373 |
1,314 |
$40K |
| 29515 |
|
1,403 |
1,366 |
$40K |
| 80349 |
|
995 |
501 |
$39K |
| 87641 |
|
1,311 |
1,221 |
$39K |
| 87186 |
|
6,608 |
6,169 |
$38K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,507 |
7,095 |
$37K |
| 93041 |
|
2,582 |
2,484 |
$36K |
| 73552 |
|
2,163 |
1,974 |
$33K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,106 |
4,580 |
$33K |
| 88304 |
|
1,763 |
1,707 |
$33K |
| 87070 |
|
7,079 |
6,807 |
$32K |
| 87400 |
|
7,827 |
7,706 |
$32K |
| 82553 |
|
4,813 |
4,202 |
$32K |
| 73060 |
|
1,921 |
1,802 |
$31K |
| J2060 |
Injection, lorazepam, 2 mg |
10,371 |
7,719 |
$30K |
| 73562 |
|
1,013 |
894 |
$30K |
| T1015 |
Clinic visit/encounter, all-inclusive |
1,778 |
442 |
$30K |
| 10060 |
|
425 |
392 |
$28K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
19,204 |
16,467 |
$28K |
| 97113 |
|
765 |
238 |
$27K |
| 95819 |
|
221 |
214 |
$27K |
| 97116 |
|
4,524 |
3,341 |
$27K |
| 82728 |
|
2,350 |
2,166 |
$26K |
| J1815 |
Injection, insulin, per 5 units |
11,325 |
4,113 |
$26K |
| 29505 |
|
327 |
317 |
$25K |
| 72170 |
|
1,069 |
1,047 |
$25K |
| C1781 |
Mesh (implantable) |
68 |
64 |
$25K |
| OP278 |
|
43 |
41 |
$25K |
| 86803 |
|
1,255 |
1,220 |
$24K |
| 87081 |
|
9,465 |
9,167 |
$24K |
| 82962 |
|
2,488 |
2,297 |
$23K |
| 36410 |
|
504 |
460 |
$23K |
| 82607 |
|
2,525 |
2,330 |
$23K |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
336 |
293 |
$22K |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
3,681 |
3,424 |
$22K |
| 70371 |
|
287 |
286 |
$22K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
976 |
931 |
$22K |
| 82803 |
|
3,130 |
2,800 |
$21K |
| 80164 |
|
2,350 |
2,000 |
$21K |
| 77334 |
|
52 |
38 |
$21K |
| 97165 |
|
1,426 |
1,320 |
$21K |
| 87077 |
|
5,489 |
5,092 |
$21K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
1,041 |
321 |
$20K |
| 74183 |
|
43 |
39 |
$20K |
| 86140 |
|
10,264 |
8,804 |
$20K |
| 97803 |
|
325 |
314 |
$20K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
7,907 |
6,102 |
$20K |
| 74230 |
|
442 |
390 |
$20K |
| 83550 |
|
2,608 |
2,437 |
$19K |
| 97802 |
|
195 |
193 |
$19K |
| 85379 |
|
9,996 |
9,551 |
$19K |
| 12011 |
|
490 |
468 |
$19K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
478 |
442 |
$18K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,688 |
5,480 |
$18K |
| 77336 |
|
202 |
90 |
$18K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
29,167 |
24,038 |
$18K |
| J2704 |
Injection, propofol, 10 mg |
14,920 |
12,047 |
$17K |
| 70544 |
|
113 |
106 |
$17K |
| 71101 |
|
837 |
806 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
34,733 |
27,098 |
$17K |
| 12002 |
|
324 |
309 |
$17K |
| 84145 |
|
2,375 |
2,044 |
$17K |
| 87340 |
|
914 |
894 |
$16K |
| 71271 |
|
236 |
234 |
$16K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
5,730 |
4,256 |
$16K |
| 84439 |
|
2,102 |
1,945 |
$16K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
7,147 |
5,365 |
$16K |
| 92611 |
|
302 |
265 |
$15K |
| 01999 |
|
178 |
176 |
$14K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
15,190 |
9,651 |
$14K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
12,328 |
9,349 |
$14K |
| 87147 |
|
3,112 |
2,992 |
$14K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
10,726 |
5,127 |
$13K |
| 82150 |
|
1,370 |
1,345 |
$13K |
| 82746 |
|
1,636 |
1,501 |
$13K |
| 77085 |
|
408 |
402 |
$13K |
| 90847 |
Family psychotherapy with the patient present, 50 minutes |
239 |
69 |
$13K |
| 97166 |
|
1,407 |
1,231 |
$13K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
4,043 |
1,921 |
$13K |
| 87205 |
|
3,832 |
3,516 |
$13K |
| 92523 |
|
103 |
100 |
$13K |
| 84132 |
|
1,270 |
696 |
$12K |
| 99152 |
|
421 |
397 |
$12K |
| 86618 |
|
892 |
869 |
$12K |
| 85007 |
|
1,852 |
1,613 |
$12K |
| 78264 |
|
68 |
64 |
$12K |
| 84703 |
|
1,119 |
964 |
$12K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
513 |
510 |
$12K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
439 |
254 |
$11K |
| 87075 |
|
2,152 |
1,990 |
$11K |
| 84520 |
|
879 |
708 |
$11K |
| 73560 |
|
427 |
356 |
$11K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
865 |
743 |
$11K |
| 83615 |
|
1,933 |
1,546 |
$11K |
| 51701 |
|
248 |
246 |
$11K |
| 97164 |
|
751 |
741 |
$11K |
| 76000 |
|
893 |
830 |
$11K |
| 82570 |
|
3,790 |
2,545 |
$11K |
| 99070 |
|
529 |
311 |
$11K |
| OP637 |
|
2,919 |
1,811 |
$10K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
527 |
513 |
$10K |
| 88313 |
|
1,076 |
1,040 |
$9K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
526 |
510 |
$9K |
| J1644 |
Injection, heparin sodium, per 1000 units |
7,374 |
3,006 |
$9K |
| 77080 |
|
119 |
119 |
$9K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,382 |
1,339 |
$9K |
| 90675 |
|
89 |
41 |
$9K |
| 82310 |
|
992 |
666 |
$9K |
| 96368 |
|
1,132 |
891 |
$9K |
| 94642 |
|
347 |
189 |
$9K |
| 80178 |
|
752 |
629 |
$9K |
| 88307 |
|
486 |
455 |
$8K |
| 80348 |
|
186 |
115 |
$8K |
| J1630 |
Injection, haloperidol, up to 5 mg |
5,526 |
4,320 |
$8K |
| 31720 |
|
31 |
25 |
$8K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
3,195 |
2,824 |
$7K |
| 85018 |
|
1,661 |
880 |
$7K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
16,359 |
12,194 |
$7K |
| 70487 |
|
85 |
80 |
$7K |
| 86780 |
|
728 |
700 |
$7K |
| 84550 |
|
1,931 |
1,643 |
$7K |
| 73221 |
|
13 |
13 |
$7K |
| 82140 |
|
1,022 |
886 |
$6K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,238 |
2,873 |
$6K |
| 97535 |
Self-care/home management training, each 15 minutes |
1,175 |
880 |
$6K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
13 |
$6K |
| 73501 |
|
201 |
178 |
$6K |
| 82784 |
|
140 |
118 |
$6K |
| 78582 |
|
111 |
109 |
$6K |
| 36600 |
|
45 |
39 |
$6K |
| 36430 |
|
544 |
366 |
$6K |
| 88300 |
|
474 |
449 |
$6K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13,287 |
9,880 |
$5K |
| J3535 |
Drug administered through a metered dose inhaler |
290 |
214 |
$5K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
228 |
187 |
$5K |
| 84075 |
|
641 |
640 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
7,614 |
3,732 |
$5K |
| 84295 |
|
640 |
637 |
$5K |
| 0012A |
|
187 |
186 |
$5K |
| J1453 |
Injection, fosaprepitant, 1 mg |
59 |
37 |
$5K |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
7,084 |
4,609 |
$5K |
| 0011A |
|
211 |
210 |
$5K |
| 78580 |
|
121 |
114 |
$5K |
| 93880 |
|
39 |
38 |
$5K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,542 |
875 |
$5K |
| 84460 |
|
806 |
805 |
$5K |
| 84450 |
|
793 |
792 |
$5K |
| 72220 |
|
239 |
239 |
$5K |
| 95816 |
|
25 |
25 |
$5K |
| 82374 |
|
644 |
639 |
$5K |
| 82435 |
|
643 |
640 |
$5K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
6,807 |
5,743 |
$5K |
| 80074 |
|
176 |
171 |
$4K |
| C9113 |
Injection, pantoprazole sodium, per vial |
2,915 |
1,886 |
$4K |
| 74247 |
|
29 |
29 |
$4K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
503 |
491 |
$4K |
| 92610 |
|
292 |
245 |
$4K |
| C1773 |
Retrieval device, insertable (used to retrieve fractured medical devices) |
316 |
294 |
$4K |
| 86920 |
|
123 |
114 |
$4K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
62 |
57 |
$4K |
| 80165 |
|
1,710 |
1,437 |
$4K |
| 72114 |
|
62 |
62 |
$4K |
| 88312 |
|
360 |
358 |
$4K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
80 |
80 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
9,992 |
8,940 |
$4K |
| 87150 |
|
186 |
153 |
$4K |
| 82040 |
|
768 |
683 |
$3K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
1,190 |
586 |
$3K |
| 83721 |
|
209 |
209 |
$3K |
| 0064A |
|
95 |
95 |
$3K |
| 84478 |
|
210 |
210 |
$3K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
281 |
272 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
31,444 |
26,455 |
$3K |
| 86706 |
|
240 |
234 |
$3K |
| 74420 |
|
73 |
70 |
$3K |
| J3480 |
Injection, potassium chloride, per 2 meq |
2,140 |
1,647 |
$3K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
5,622 |
4,727 |
$3K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,267 |
1,888 |
$3K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,535 |
970 |
$3K |
| 86787 |
|
191 |
190 |
$3K |
| J1953 |
Injection, levetiracetam, 10 mg |
978 |
698 |
$3K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
112 |
107 |
$3K |
| 80362 |
|
61 |
43 |
$3K |
| 96415 |
|
32 |
25 |
$3K |
| J3411 |
Injection, thiamine hcl, 100 mg |
1,393 |
833 |
$3K |
| 76820 |
|
46 |
27 |
$3K |
| 94760 |
|
1,811 |
904 |
$3K |
| A9540 |
Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
221 |
201 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
48 |
47 |
$2K |
| 73521 |
|
54 |
54 |
$2K |
| 72146 |
|
12 |
12 |
$2K |
| 94060 |
|
14 |
14 |
$2K |
| 82247 |
|
326 |
249 |
$2K |
| 93923 |
|
24 |
24 |
$2K |
| 72158 |
|
14 |
14 |
$2K |
| 80358 |
|
133 |
94 |
$2K |
| 76641 |
|
31 |
28 |
$2K |
| 72200 |
|
134 |
133 |
$2K |
| 82947 |
|
475 |
427 |
$2K |
| 86923 |
|
399 |
289 |
$2K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,277 |
1,080 |
$2K |
| 73700 |
|
25 |
24 |
$2K |
| 29130 |
|
76 |
74 |
$2K |
| 94660 |
|
150 |
97 |
$2K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
3,842 |
2,561 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
92 |
88 |
$2K |
| J7999 |
Compounded drug, not otherwise classified |
3,650 |
2,335 |
$2K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,392 |
1,508 |
$2K |
| 73620 |
|
52 |
48 |
$2K |
| 99153 |
Mod sedat endo service >5yrs |
75 |
73 |
$2K |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
1,562 |
1,055 |
$2K |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
14 |
13 |
$2K |
| C1758 |
Catheter, ureteral |
13 |
12 |
$1K |
| 85046 |
|
259 |
144 |
$1K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
131 |
105 |
$1K |
| 85014 |
|
42 |
27 |
$1K |
| 87088 |
|
389 |
383 |
$1K |
| 84156 |
|
487 |
447 |
$1K |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
121 |
108 |
$1K |
| 87449 |
|
52 |
51 |
$1K |
| 86592 |
|
486 |
482 |
$1K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
14 |
14 |
$1K |
| 94770 |
|
81 |
81 |
$1K |
| 82465 |
|
208 |
208 |
$1K |
| 77061 |
|
112 |
109 |
$1K |
| 96523 |
|
57 |
42 |
$1K |
| 10061 |
|
24 |
24 |
$1K |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
13 |
12 |
$1K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,720 |
1,341 |
$1K |
| 82010 |
|
308 |
249 |
$1K |
| 86738 |
|
16 |
14 |
$1K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
992 |
444 |
$1K |
| 85384 |
|
87 |
79 |
$1K |
| 87420 |
|
277 |
273 |
$1K |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
231 |
185 |
$997.57 |
| J1940 |
Injection, furosemide, up to 20 mg |
911 |
533 |
$986.36 |
| 70360 |
|
62 |
62 |
$949.57 |
| 86308 |
|
742 |
719 |
$921.81 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
570 |
534 |
$918.13 |
| 87536 |
|
38 |
37 |
$911.66 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
710 |
563 |
$895.37 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
9,351 |
7,033 |
$889.21 |
| 93356 |
|
30 |
27 |
$858.49 |
| 73000 |
|
28 |
25 |
$832.95 |
| 82248 |
|
265 |
258 |
$827.27 |
| J9267 |
Injection, paclitaxel, 1 mg |
55 |
25 |
$809.10 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
27 |
26 |
$764.18 |
| 86038 |
|
133 |
124 |
$733.01 |
| 87493 |
|
99 |
91 |
$731.22 |
| 88311 |
|
214 |
196 |
$717.09 |
| OP271 |
|
108 |
89 |
$667.35 |
| 85651 |
|
345 |
336 |
$647.85 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
196 |
184 |
$605.62 |
| A9558 |
Xenon xe-133 gas, diagnostic, per 10 millicuries |
94 |
92 |
$599.74 |
| 94729 |
|
19 |
19 |
$555.29 |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
13 |
12 |
$541.05 |
| J3250 |
Injection, trimethobenzamide hcl, up to 200 mg |
53 |
36 |
$521.17 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
13 |
13 |
$502.17 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
57 |
57 |
$502.17 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
57 |
57 |
$502.17 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
73 |
73 |
$502.17 |
| 94727 |
|
19 |
19 |
$452.94 |
| 70250 |
|
16 |
13 |
$441.09 |
| J3230 |
Injection, chlorpromazine hcl, up to 50 mg |
18 |
12 |
$435.40 |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
1,001 |
668 |
$433.72 |
| J1245 |
Injection, dipyridamole, per 10 mg |
58 |
54 |
$421.88 |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$417.15 |
| 0031A |
|
16 |
16 |
$408.63 |
| 90682 |
|
19 |
16 |
$403.68 |
| 90686 |
|
98 |
88 |
$403.07 |
| 73100 |
|
17 |
15 |
$385.70 |
| 86762 |
|
41 |
41 |
$381.40 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
537 |
455 |
$378.58 |
| 97163 |
|
19 |
18 |
$376.54 |
| 73120 |
|
13 |
13 |
$375.29 |
| 86318 |
|
141 |
140 |
$369.78 |
| 84315 |
|
124 |
71 |
$346.72 |
| 29540 |
|
44 |
41 |
$346.31 |
| 74020 |
|
19 |
19 |
$345.70 |
| 86666 |
|
28 |
28 |
$343.18 |
| 86757 |
|
26 |
26 |
$296.64 |
| 29105 |
|
12 |
12 |
$290.92 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
266 |
195 |
$273.84 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,474 |
1,239 |
$254.21 |
| 86753 |
|
30 |
30 |
$244.69 |
| 88302 |
|
25 |
24 |
$235.49 |
| J7510 |
Prednisolone oral, per 5 mg |
418 |
384 |
$223.20 |
| 88112 |
|
12 |
12 |
$213.11 |
| 88142 |
|
13 |
13 |
$211.10 |
| 29530 |
|
17 |
17 |
$204.45 |
| 80156 |
|
12 |
12 |
$204.16 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25 |
24 |
$200.57 |
| 82043 |
|
77 |
76 |
$182.97 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
82 |
74 |
$181.01 |
| 90732 |
|
21 |
21 |
$178.48 |
| 76080 |
|
13 |
12 |
$173.29 |
| C1729 |
Catheter, drainage |
55 |
42 |
$164.34 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
30 |
13 |
$161.42 |
| 86665 |
|
14 |
12 |
$158.40 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
371 |
300 |
$152.30 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
387 |
358 |
$118.70 |
| 73140 |
|
26 |
26 |
$111.67 |
| 84436 |
|
27 |
27 |
$109.50 |
| 83020 |
|
15 |
15 |
$105.00 |
| 82330 |
|
27 |
24 |
$95.18 |
| 86701 |
|
12 |
12 |
$89.25 |
| J1836 |
Injection, metronidazole, 10 mg |
171 |
112 |
$82.38 |
| 84480 |
|
14 |
14 |
$78.75 |
| 86664 |
|
14 |
12 |
$66.80 |
| 82365 |
|
86 |
81 |
$64.14 |
| 90662 |
|
16 |
14 |
$62.58 |
| 82565 |
|
15 |
12 |
$51.75 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
198 |
118 |
$44.95 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
224 |
199 |
$39.25 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
186 |
110 |
$30.27 |
| 85652 |
|
36 |
33 |
$25.05 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
63 |
63 |
$18.27 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
23 |
14 |
$15.31 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
62 |
57 |
$11.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
14 |
12 |
$9.91 |
| 89050 |
|
29 |
24 |
$5.80 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
150 |
108 |
$4.42 |
| G0008 |
Administration of influenza virus vaccine |
190 |
161 |
$2.62 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
753 |
689 |
$2.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
105 |
100 |
$1.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
15 |
15 |
$1.00 |
| 91301 |
|
455 |
439 |
$0.01 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
80 |
79 |
$0.00 |
| Q9969 |
Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose |
35 |
33 |
$0.00 |
| 90656 |
|
21 |
16 |
$0.00 |
| OP324 |
|
19 |
19 |
$0.00 |
| 91303 |
|
15 |
15 |
$0.00 |
| 91306 |
|
90 |
90 |
$0.00 |
| 64484 |
|
18 |
15 |
$0.00 |
| 91305 |
|
18 |
18 |
$0.00 |